Parathyroid hormone (rDNA origin) (Preos, NPS Pharmaceuticals) for the treatment of osteoporosis.
Approvable designations
Priority review
Fast-track designations
Medicare’s Drug Price Negotiations Could Impact Physician Reimbursement
September 19th 2024When CMS begins negotiations for physician-administered drugs under the Inflation Reduction Act, providers, including those whose services are covered by commercial insurance, could see lowered reimbursement.
Read More